Inhibition of Protein Isoprenylation and p21ras Membrane Association by Dehydroepiandrosterone in Human Colonie Adenocarcinoma Cells in Vitro

Cancer Research

Volumn 51, Issue 24, 1991, Pages 6563-6567

  Nyce, Jonathan W ^a,a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEVINOLIN; PRASTERONE;

ARTICLE; CARCINOGENESIS; COLON ADENOCARCINOMA; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL COMPARTMENTATION; CELL DIVISION; CELL MEMBRANE; COLONIC NEOPLASMS; HUMAN; IN VITRO; LOVASTATIN; MEVALONIC ACID; PRASTERONE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEIN P21(RAS); SUPPORT, NON-U.S. GOV'T; TERPENES; TUMOR CELLS, CULTURED;

EID: 0026344261     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Schwartz, A. G. Whitcomb, J. M., Nyce, J. W., Lewbart, M. L., and Pashko, L. L. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv. Cancer Res., 51:391-424,1988.
2. Gordon, G. B., Shantz, L. M., and Talalay, P. Modulation of growth, differentiation, and carcinogenesis by dehydroepiandrosterone. Adv. Enzyme Regul., 26: 355-382, 1987.
3. Zumoff, B., Rosenfeld, R., Strain, G. W., Levin, J., and Fukushima, D. K. Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DMAS) and the DHA to DHAS ratio in normal adults. J. Clin. Endocrinol. Metab., SI: 330-333, 1980.
4. Orentreich, N., Brind, J. L., Rizer, R. L., and Vogelman, J. H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab., 59:551-555, 1984.
5. Farewell, V. T., Bulbrook, R. D., and Hayward, J. L. Risk factors in breast cancer: a prospective study on the island of Guernsey. In: E. P. Grundmann and L. Beck (eds.). Cancer Campaign. Early Diagnosis of Breast Cancer. Methods and Results, Vol. 1, pp. 43-51. Stuttgart, Germany: Gustaf Fischer Verlag, 1978.
6. Gordon, G. B., Helzlsouer, K. J., and Comstock, G. W. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. Cancer Res., 51:1366-1369,1991.
7. Nyce, J. W., Magee, P. N., Hard, G. C., and Schwartz, A. G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis (LOND.), 5: 57-62, 1984.
8. Schwartz, A. G., and Tannen, R. H. Inhibition of 7,12-dimethylbenz[a] anthracene-and urethan-induced lung tumor formation in A/J mice by longterm treatment with dehydroepiandrosterone. Carcinogenesis (LOND.), 2: 1335-1337,1981.
9. Moore, M. A., Thamavit, W., Ichihara, A., Sato, K., and Ito, N. Influence of dehydroepiandrosterone, diaminopropane and butylated hydroxyanisole treatment during the induction phase of rat liver nodular lesions in a shortterm system. Carcinogenesis (LOND.), 7:1059-1063,1986.
10. Garcea, R., Daino, L., Pascale, R., Frassetto, S., Cozzolino, P., Ruggiu, M. E., and Feo, F. Inhibition by dehydroepiandrosterone of liver putative preneoplastic foci formation in rats subjected to the initiation-selection process of experimental carcinogenesis. Toxicol. Pathol., 15: 164-169, 1987.
11. Garcea, R., Daino, L., Frassetto, S., Cozzolino, P., Ruggiu, M. E., Vannini, M. G., Pascale, R., Lenzerini, L., Simile, M. M., Puddu, M., et al. Reversal by ribo-and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental carcinogenesis. Carcinogenesis (LOND.), 9: 931-938, 1988.
12. Thornton, M., Moore, M. A., and Ito, N. Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic preneoplastic lesions in rat. Carcinogenesis (LOND.), 10:407-410,1989.
13. Schwartz, A. G. Inhibition of spontaneous breast cancer formation in female C3H (A'/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res., 39: 1129-1132, 1979.
14. Feo, F., Seddaiu, M. A., Daino, L, Simile, M. M., Pascale, R., McKeating, J. A., Davliacos, G. P., Sudol, K. S., Melhem, M. F., and Rao, K. N. Eflects of dehydroepiandrosterone on DNA and cholesterol biosynthesis in hepato-carcinoma in rats. Proc. Am. Assoc. Cancer Res., 32:125,1991.
15. Gianelly, A. A., and Temer, C. Inhibition of cholesterol biosynthesis by dehydroepiandrosterone in lactating mammary gland. Endocrinology, 83: 1311-1315,1968.
16. Maltese, W. A. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J., 4:3319-3329,1990.
17. Schmidt, R. A., Schneider, C. J., and Glomset, J. A. Evidence for posttranslational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J. Biol. Chem., 259:10175-10180,1984.
18. Maltese, W. A., and Sheridan, K. M. Isoprenoid synthesis during the cell cycle. J. Biol. Chem., 263:10104-10110,1988.
19. Maltese, W. A., and Erdman, R. A. Characterization of isoprenoid involved in the post-translational modification of mammalian cell proteins. J. Biol. Chem., 264: 18168-18172,1989.
20. Repko, E. M., and Maltese, W. A. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J. Biol. Chem., 264:9945-9952, 1989.
21. Barbacid, M. Ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
22. Bos, J. L. Ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1990.
23. Willumsen, B. M., Christensen, A., Hubbert, N. I., Papageorge, A. G., and Lowy, D. R. The p21 ras terminus is required for transformation and membrane association. Nature (LOND.), 310: 583-586, 1984.
24. Gutierrez, L., Magee, A. I., Marshall, C. J., and Hancock, J. F. Posttranslational processing of P21 is two-step and involves carboxyl-methyla-tion and carboxy-terminal proteolysis. EMBO J., 8: 1093-1098, 1989.
25. Hancock, J. T., Magee, A. I., Childs, J. E., and Marshall, C. J. Ail ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57: 1167-1177, 1989.
26. Casey, P. J., Solski, P. A., Der, C. J., and Buss, J. E. p21 ras is modified by a famesyl isoprenoid. Proc. Natl. Acad. Sci. USA, 86:8323-8327, 1989.
27. Leonard, S., Beck, L., and Sinensky, M. Inhibition of isoprenoid biosynthesis and the post-translational modification of pro-p21. J. Biol. Chem., 265: 5157-5160, 1990.
28. Lowy, D. R., and Willumsen, B. M. New clue to ras lipid glue. Nature (LOND.), 341: 384-385,1989.
29. Kita, T., Brown, M. S., and Goldstein, J. L. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J. Clin. Invest., 66: 1094-1107,1980.
30. Clarke, S., Vogel, J. P., Deschenes, R. J., and Stock, J. Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases. Proc. Natl. Acad. Sci. USA, 85: 46434647, 1988.
31. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (LOND.), 227: 680-685, 1970.
32. Ward, S., Wilson, D. L., and Gilliam, J. J. Methods for fractionation and scintillation counting of radioisotope-labeled polyacrylamide gels. Anal. Biochem., 38:90-97, 1970.
33. Bordier, C. Phase separation of integral membrane proteins in Triton-Xl 14. J. Biol. Chem., 256: 1604-1607, 1981.
34. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76:4350-4354, 1979.
35. Maltese, W. A., and Sheridan, K. M. Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation. J. Cell. Physiol., 133: 471-481, 1987.
36. Maltese, W. A., and Sheridan, K. M. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J. Cell. Physiol., 125: 540-558, 1985.
37. Sinensky, M., Beck, L. A., Leonard, S., and Evans, R. Differential inhibitory eflects of lovastatin on protein isoprenylation and sterol synthesis. J. Biol. Chem., 265: 19937-19941, 1990.
38. Mendola, C. E., and Backer, J. M. Lovastatin blocks N-ro5 oncogene-induced neuronal differentiation. Cell Growth & Differ., 1:499-502, 1990.
39. Buss, J. E., and Sefton, B. M. Direct identification of palmitic acid as the lipid attached to p21~. Mol. Cell. Biol., 6: 116-122, 1986.
40. Quesney-Huneeus, V., Wiley, M. H., and Siperstein, M. D. Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA, 76:5056-5060, 1979.
41. Habenicht, A. J. R., Glomset, J. A., and Ross, R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem., 255: 5134-5140, 1980.
42. Fairbanks, K. P., Witte, L. D., and Goodman, D. S. Relation between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J. Biol. Chem., 259: 1546-1551,1984.
43. Keyomarsi, K., Sandovai, L., Band, V., and Pardee, A. B. Synchronization of tumor and normal cells from Gi to multiple ceil cycles by lovastatin. Cancer Res., 51:3602-3609,1991.
44. Marks, P. A., and Banks, J. Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids. Proc. Natl. Acad. Sci. USA, 46:447-452, 1960.
45. Nyce, J., Klann, R., and Holbrook, C. T. Biochemical modulation of 5-fluoropyrimidine toxicity by dehydroepiandrosterone in human colonic adenocarcinoma cells. Cancer Commun., 2: 213-217, 1990.
46. Dworkin, C. R., Gorman, S. D., Pashko, L. L., Cristofalo, V. J., and Schwartz, A. G. Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides. Life Sci., 38: 1451-1457, 1986.
47. Schwartz, A. G., and Perantoni, A. Protective effect of dehydroepiandrosterone against aflatoxin B|-and 7,12-dimethyl-benz[a]anthracene-induced cytotoxicity and transformation in cultured cells. Cancer Res., 35:2482-2487, 1975.